Home
Welcome to the homepage of the Hopkins Medical Device Network.
Hopkins Medical Device Network (HMDN) is a student-run organization at the Johns Hopkins University that provides medical device development opportunities outside of the Design Team course, which is run by the Whitaker Biomedical Engineering Department. HMDN focuses on the educational aspect of medical device research and development, as well as team work and management. HMDN also encourages generating creative and innovative solutions to current medical problems. In addition, the organization facilitates networking with engineers, doctors, IP lawyers, entrepreneurs and venture capitalists. Such opportunities are not currently widespread at Johns Hopkins University, and there is a growing demand for an organization to provide them.
Our mission is to promote the development of medical device technologies at JHU by:
- Facilitating networking opportunities with students and professionals with similar interests
- Advising and supporting students engaged in research and the development of medical devices
- Connecting students with researchers, industry representatives and potential clients
- Educating and preparing students for the process of medical device development
by
Bryce Chiang on
April 1st, 2009
Hopkins Medical Device Network is accepting applications for the 2009 Executive Board
Join us as we promote medical device development and entrepreneurship at Johns Hopkins University.
Applications are due by midnight on April 5th, 2009. Email your completed application to hmdn@jhu.edu.
Find the application here: hmdn_2009application
Category:
Announcements |
No Comments
by
Bryce Chiang on
March 30th, 2009
Kevin Warwick, of the University of Reading has developed a car with a brain. Although his goal is not to prevent accidents, he has shown that a set of neurons spontaneously made connections with each other and sensor electrodes to create a neural network for driving. Currently the robot uses only a sonar input, but it will soon be equipped with auditory inputs. State officials have not yet ruled if it will be prosecuted for drunk driving if accidentally sprayed with 70% ethanol.
Libra DBS has begun trials of their deep brain stimulator in Europe. Like a pacemaker, this internal device will have leads running and an internal battery to influence the body regulatory system with electricity. Unlike a pacemaker, however, this will have leads into the brain.
A patient in Denmark was shocked soon after receiving an implantable defibrillator. Physicians, at a loss for explanation, decided to bring in electricians to solve the problem. After returning to the patient’s house, they realized that faulty wiring for a washing machine had caused his defibrillator to be activated. Similar cases have occurred in Hong Kong, Germany, and likely the next season of House.
Category:
Digest |
No Comments
by
Bryce Chiang on
March 12th, 2009
Find the videos of each presentation as well as the presentations here.
Category:
Uncategorized |
No Comments
by
Bryce Chiang on
March 12th, 2009
March 10, 2009 6:00 PM
Dr. Daniel Schultz, Director of the FDA’s Center for Devices and Radiological Health (CDRH)
| Date: |
Tuesday, March 10th 2009 |
| Time: |
6 pm to 7 pm (Exclusive networking event to follow) |
| Location: |
JHU Homewood Campus, Computational Science & Engineering Building (CSEB) Auditorium |
| Cost: |
FREE, LIGHT REFRESHMENTS WILL BE SERVED |
Come join HMDN as we host Dr. Daniel Schultz, Director of the FDA’s Center for Devices and Radiological Health, along with Nancy Pluhowski, the Director of the Medical Device Fellowship program and Courtney Harper of the Office of InVitro Diagnostic Device Safety and Evaluation. Dr. Schultz will speak on the medical device approval process along with what it takes to successfully bring a novel medical device to market. Courtney Harper will explain current trends in diagnostic laboratory tests, while Nancy Pluhowski will talk about employment opportunities at the FDA.
Dr. Dan Schultz holds a bachelor’s degree in political science from the City College of New York and received his medical degree from the University of Pittsburgh in 1974. He is board certified in general surgery and family practice. Dr. Schultz entered the Commissioned Corps of the US Public Health Service in 1974, where he served in the PHS Indian Health Service as a hospital clinical director and a surgical resident. In 1983 he was appointed Chief of Surgery at the Indian Health Service Hospital inSanta Fe, New Mexico, a post he held for 11 years. In 1994 Dr. Schultz joined the Center for Devices and Radiological Health of the FDA, where he served in CDRH’s Office of Device Evaluation, first as a medical officer, then a Division Director, then the Office’s Deputy Director and finally its Director. He was promoted to Director of CDRH in 2004.
_______________________________________________
Below are the presentation files from our speakers. Feel free to look at them for reference:
Category:
Events |
No Comments
by
Bryce Chiang on
March 9th, 2009
Volume 1: Issue 17 03/09/09
REPEL-CV is a new, FDA approved, bioresorbable temporary barrier for adhesion prevention after cardiac surgery. Adhesions are scar tissue which form between sets of tissue which should not be connected. This barrier is broken down in vivo and is to be used in children.
Preliminary testing has shown that a mixture of neural stem cells and a biodegradable polymer will allow regeneration of tissue killed during a stroke. Angiogenic factors are also added to promote blood flow. Initial tests with rats have been promising.
CorNova has developed a new angioplasty balloon with fiber optic sensors to determine whether the vessel has been adequately dilated. The balloon is able to determine whether the stent is properly placed and expanded, an issue which may present serious future problems and be a possible thromogenic cause.
Category:
Digest |
No Comments
